Abstract:As desirable contrast agents for magnetic resonance imaging (MRI), ultrasmall superparamagnetic iron oxides (USPIOs) are required to exhibit both low cytotoxicity and specific targetability besides superparamagnetism to achieve better imaging contrast at lower dose, and cladding with biocompatible polymers and modification with targeting ligands are considered to be the most effective strategies. In this study, novel dextran wrapped and peptide WSGPGVWGASVK (peptide-WSG) grafted USPIOs were meticulously prepared and systematically characterized. Firstly, dextran (Dex) cladded USPIOs (USPIOs@Dex) were synthesized with a well-designed co-precipitation procedure in which the biocompatible dextran played dual roles of grain inhibitor and cladding agent. After that, sodium citrate was applied to carboxylize the hydroxyls of the dextran molecules via an esterification reaction, and then tumor targeting peptide-WSG was grafted to the carboxyl groups by the EDC method. The XRD, TEM, and FTIR results showed that inverse spinel structure Fe3O4 crystallites were nucleated and grown in aqueous solution, and the catenulate dextran molecules gradually bound on their surface, meanwhile the growth of grains was inhibited. The size of original crystallite grains was about 7 nm, but the mean size of USPIOs@Dex aggregates was 165.20 nm. After surface modification by sodium citrate and peptide-WSG with ultrasonic agitation, the size of the USPIOs@Dex-WSG aggregates was smaller (66.06 nm) because the hydrophilicity was improved, so USPIOs@Dex-WSG could evade being eliminated by RES more easily, and prolong residence time in blood circulation. The VSM and T-2-weighted MRI results showed that USPIOs@Dex-WSG were superparamagnetic with a saturation magnetization of 44.65 emu g(-1), and with high transverse relaxivity as the R-2 relaxivity coefficient value was 229.70 mM(-1) s(-1). The results of MTT assays and the Prussian blue staining in vitro revealed that USPIOs@Dex-WSG exhibited nontoxicity for normal cells such as L929 and HUVECs, and were specifically targeted to the SKOV-3 cells. Thus, the novel dextran wrapped and WSG-peptide grafted USPIOs have potential to be applied as tumor active targeting contrast agents for MRI.

Studies on Water-Soluble Metalloporphyrins As Tumor Targeting Magnetic Resonance Imaging Contrast Agents

Gadolinium-based contrast agents for tumor targeting imaging

Synthesis and in Vitro and in Vivo Evaluation of Manganese(Iii) Porphyrin-Dextran As A Novel Mri Contrast Agent

A Ph-Responsive T1-T2 Dual-Modal MRI Contrast Agent for Cancer Imaging

Synthesis and Tumor Targeting Distribution of Water Soluble ~(188)Re-Meso-tetrakis(4-sulfophenyl) Porphyrin

Fe3O4 Nanoparticles Functionalized with Polymer Ligand for T-1-Weighted MRI in Vitro and in Vivo

Radiolabeled, Antibody-Conjugated Manganese Oxide Nanoparticles for Tumor Vasculature Targeted Positron Emission Tomography and Magnetic Resonance Imaging

One pot synthesis of zwitteronic 99mTc doped ultrasmall iron oxide nanoparticles for SPECT/T1-weighted MR dual-modality tumor imaging

Fabrication and Evaluation of Tumor-Targeted Positive MRI Contrast Agent Based on Ultrasmall MnO Nanoparticles.

Ultrasmall Water-Soluble Metal-Iron Oxide Nanoparticles As T1-weighted Contrast Agents for Magnetic Resonance Imaging.

Cubic Zinc-Doped Iron Oxide Nanoparticles with Poly(Ethylene Glycol) or Sodium Citrate Surface Coatings for Tumor Imaging

Magnetic resonance imaging (MRI) contrast agents for tumor diagnosis.

Mitochondria-targeting Pt/Mn Porphyrins As Efficient Photosensitizers for Magnetic Resonance Imaging and Photodynamic Therapy

Engineered magnetic hybrid nanoparticles with enhanced relaxivity for tumor imaging

A Manganese Porphyrin Platform for the Design and Synthesis of Molecular and Targeted MRI Contrast Agents

Mn(ii) Chelate-Coated Superparamagnetic Iron Oxide Nanocrystals As High-Efficiency Magnetic Resonance Imaging Contrast Agents

Theranostic porphyrin dyad nanoparticles for magnetic resonance imaging guided photodynamic therapy.

Gadolinium(III) Porphyrinoid Phototheranostics.

Preparation and characterization of peptide modified ultrasmall superparamagnetic iron oxides used as tumor targeting MRI contrast agent

Transition metal doped hydrophilic ultrasmall iron oxide modulate MRI contrast performance for accurate diagnosis of orthotopic prostate cancer

Ultrasmall MnSe Nanoparticles As T1-MRI Contrast Agents for in Vivo Tumor Imaging.